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Background: AMP- activated protein kinase (AMPK) is a fundamental enzyme expressed in most mammalian tissue regulating energy-generating 
pathway in response to metabolic needs. AMPK also involves eNOS-mediate signaling pathway. Doxorubicin (DXR) is chemotherapeutic agents 
with dose-dependent cardiotoxicity through the mechanism of impairment of myocyte energetics, apoptosis, and decrease of AMPK activity. 
Metformin, drugs for type 2 diabetes, is an activator of AMPK. We hypothesized that metformin could play a role in cardioprotection in DXR-induced 
cardiomyopathy in mice.
Methods: Male C57BL/6 mice (16-20 g) used. A single dose of DXR (20 mg/kg), follwed by low (125 mcg/kg) and high (200 mg/kg) dose 
metformin at 0, 24 and 48 hours after DXR injected intraperitoneally, then mice sacrificed 72 hours thereafter. The left ventricle (LV) was cut 
prepared for Western blot analysis of AMPK and phosphorylated AMPK (AMPK-P) activity and immunohistochemical stain with polyclonal anti-3NT 
antibody.
Results: Administration of metformin activates AMPK in the LV in Western blots performing at 72 hours following injection of metformin (fig-upper). 
Polyclonal rabbit anti-3-NT detected no protein nitration in control but marked presence in DXR group. High or low dose metformin treatments 
showed protective effect (fig-lower).
Conclusions: Metformin, could impair DXR-induced cardiomyopathy by the mechanism of AMPK activation and suppression of nitration.
